-+ 0.00%
-+ 0.00%
-+ 0.00%
A Look At Aflac (AFL) Valuation After Japan Reinsurance Deal And New Long Term Care Product
Share
Listen to the news

Aflac (AFL) has drawn attention after Aflac Re Bermuda agreed to reinsure a block of whole life annuities from Japan Post Insurance through coinsurance, while also rolling out a new long term care focused life product.

See our latest analysis for Aflac.

Aflac’s recent reinsurance deal in Japan and new long term care life product in the U.S. come as the share price sits at US$110.48, with a 7 day share price return of 3.82% but a slightly negative 90 day share price return, while longer term total shareholder returns of 10.68% over 1 year and 139.91% over 5 years indicate momentum has been stronger over multi year periods than in recent months.

If this kind of insurance driven story interests you, it can be useful to see what else is moving and compare business models through a broader screen of financials. For a wider view across the market, now could be a good time to broaden your search and look at 20 top founder-led companies

With the shares around US$110, a modest 1-year total return of 10.68%, and an intrinsic value estimate suggesting a discount of about 38%, is Aflac still overlooked here, or is the market already pricing in future growth?

Most Popular Narrative: 2.2% Undervalued

With Aflac’s shares at $110.48 versus a fair value narrative anchored at $113.00, the current pricing sits close to what analysts' models imply.

Ongoing diversification and optimization of Aflac's investment portfolio, including the proactive management of yen

and USD-denominated assets, positions the company to better withstand interest rate cycles and enhance investment income stability, reducing earnings volatility and supporting sustainable bottom-line growth.

Read the complete narrative.

Curious what sits behind that fair value gap? The narrative leans on steady revenue, firm margins, and a valuation multiple that assumes earnings power holds up.

Have a read of the narrative in full and understand what's behind the forecasts.

However, the picture is not one way. Ongoing premium pressure in Japan and softer U.S. sales growth both carry the potential to upset this valuation story.

Find out about the key risks to this Aflac narrative.

Another Lens on Valuation

Analysts see Aflac as close to fairly priced at $110.48 versus a $113.00 target, but the current P/E of 15.6x tells a tougher story. It sits above peers at 14.3x and above an estimated fair ratio of 11.6x, which points to less room for error if earnings disappoint.

To see what the numbers say about this valuation gap, and how much room there might be for that P/E to move toward the fair ratio, See what the numbers say about this price — find out in our valuation breakdown.

NYSE:AFL P/E Ratio as at Apr 2026
NYSE:AFL P/E Ratio as at Apr 2026

Next Steps

The signals are mixed so far, with both concerns and positives in the story. Review the underlying data now and weigh it against the 2 key rewards and 1 important warning sign.

Looking for more investment ideas?

If Aflac is on your radar, do not stop there. Broaden your watchlist now and give yourself more options before the next wave of opportunities hits.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending